hypercholesterolemia

Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
Drugs.com
Mon, 08/28/23 - 08:23 pm
Merck
clinical trials
MK-0616
hypercholesterolemia
AstraZeneca returns to hypercholesterolemia via R&D pact with fresh-faced Chinese biotech
Fierce Biotech
Fri, 06/16/23 - 09:59 am
AstraZeneca
hypercholesterolemia
R&D
Cholesgen
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
NASDAQ.com
Tue, 06/26/18 - 09:47 am
Amgen
Repatha
type 2 diabetes
diabetes
hypercholesterolemia
ADA
PDUFA test 3
Tue, 04/10/18 - 12:00 am
Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
Yahoo/PR Newswire
Sun, 08/31/14 - 09:56 am
Sanofi
Regeneron
alirocumab
hypercholesterolemia
Harvard Study Questioning Cholesterol Drugs in Low-Risk Cases Survives Oxford Challenge
BusinessWeek
Sat, 08/2/14 - 10:33 am
hypercholesterolemia
statins
New Detailed Phase 3 Data Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With A Rare And Serious Genetic Disorder That Causes High Cholesterol
Yahoo/PR NewsWire
Sun, 06/1/14 - 11:57 am
cholesterol
hypercholesterolemia
evolocumab
Amgen
FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade
Forbes
Sat, 03/8/14 - 10:31 am
PCSK9 inhibitors
Regeneron
Sanofi
hypercholesterolemia
Amgen Goes 6 for 6 Fighting Cholesterol
Motley Fool
Sat, 02/1/14 - 10:52 am
Amgen
cholesterol
hypercholesterolemia
evolocumab
Amgen Inc’s Next Blockbuster Drug Delivers
Motley Fool
Sat, 01/25/14 - 10:54 am
Amgen
AMG 145
hypercholesterolemia
cholesterol
The Next Cholesterol-Fighting Blockbuster Drug?
Motley Fool
Sun, 10/20/13 - 02:44 pm
cholesterol
hypercholesterolemia
Regeneron
Sanofi
alirocumab
EMA rejects Genzyme re-examination request for Kynamro
Yahoo/Fly on the Wall
Fri, 03/22/13 - 11:29 am
Europe
Genzyme
Kynamro
Sanofi
hypercholesterolemia
New drug holds promise as therapy for rare and deadly cholesterol disorder
Equities.com
Sun, 11/4/12 - 10:43 am
lomitapide
hypercholesterolemia
Aegerion
Isis Trading Halts as FDA Reviews Key Drug's Risks
PharmPro
Sat, 10/20/12 - 10:49 am
Isis Pharmaceuticals
Kynamro
hypercholesterolemia
Aegerion CEO on Cholesterol Drug Lomitapide
Bloomberg
Sat, 10/20/12 - 10:37 am
Aegerion
lomitapide
hypercholesterolemia
Kowa Pharma, Eli Lilly PREVAIL US study of Livalo met primary endpoint of LDL-C reduction
Pharmabiz
Sun, 06/3/12 - 12:35 pm
Eli Lilly
Livalo
hypercholesterolemia
LDL cholesterol
Aegerion Pharmaceuticals Announces Lomitapide 78-Week Phase III Clinical Data Consistent With Earlier Results
Yahoo/Globe NewsWire
Sat, 01/7/12 - 12:42 pm
Aegerion
lomitapide
hypercholesterolemia
Next big drug against cholesterol takes shape
HealthNews
Sat, 08/27/11 - 01:35 pm
Regeneron
Sanofi
hypercholesterolemia
PCSK9
Amgen
Merck
Alnylam
Bristol-Myers Squibb
REGN727
Genzyme and Isis submit European MAA for mipomersen
Pharmabiz
Sat, 07/30/11 - 12:26 pm
Genzyme
Isis Pharmaceuticals
mipomersen
hypercholesterolemia
Valeant's subsidiary Biovail acquires Canadian rights to Cholestagel from Genzyme
pharmabiz
Sat, 02/12/11 - 02:26 pm
Biovail
Genzyme
Cholestagel
hypercholesterolemia
colesevelam